Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLN.L Share News (SLN)

  • There is currently no data for SLN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK EXECUTIVE CHANGE SUMMARY: Iofina Recruits Former Oklahoma Governor

Thu, 02nd Apr 2020 13:07

(Alliance News) - The following is a round-up of company director and manager changes announced on Wednesday and Thursday and not separately reported by Alliance News:

----------

Iofina PLC - Hires Mary Fallin as non-executive director. Fallin is the former governor of the US state of Oklahoma, where Iofina operates four iodine extraction plants. "Throughout her time in politics she has been a great advocate of small and medium-sized enterprises like Iofina and so to have her join the team during this next phase of growth is really exciting for us," said Iofina Chief Executive Officer Tom Becker.

----------

BAE Systems PLC - Hires former Johnson & Johnson executive Jane Griffiths as non-executive director from Wednesday. Last role was as global head of Actelion, leading the integration of the Swiss biotech company following its acquisition by the US's J&J. Nick Rose agrees to remain as non-executive director for another year.

----------

Serinus Energy PLC - Hires former BP PLC geophysicist Andy O'Donovan as chief operating officer from Wednesday.

----------

Ingenta PLC - Hires Sebastian White as non-executive director, as Max Royde steps down, both immediately. White is investment director for Kestrel Partners LLP, a 27% shareholder of Ingenta.

----------

RDL Realisation PLC - Dominik Dolenec resigns as director in accordance with terms of the standstill agreement between Oaktree Value Equity Holdings LP and LIM Advisors (London) Ltd.

----------

Ince Group PLC - Financial Controller Simon Oakes steps up to chief financial officer, as announced back in January, with Christopher Yates stepping down. Anthony Edwards steps down as non-executive chair and as director, with Senior Non-Executive Director David Furt taking on the chair.

----------

KRM22 PLC - CFO Kim Suter added to the board immediately as executive director. Karen Bach, a founder of KRM22 and former COO, steps down as non-executive director.

----------

Hargreaves Services PLC - Hires Christopher Jones as non-executive director, from Wednesday. Jones is a veteran of the UK commercial property market, founding Manchester-based Christopher Dee LLP.

----------

e-Therapeutics PLC - Hires Laura Roca-Alonso as chief business officer. Was head of Corporate Development at Silence Therapeutics PLC.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
10 Oct 2018 11:49

Silence Therapeutics Files Interim Injunction Against Alnylam

LONDON (Alliance News) - Silence Therapeutics PLC said Wednesday it filed a cross-border interim injunction application to stop Alnylam Pharmaceuticals Inc from commercialising patisiran drug drug

Read more
11 Sep 2018 12:44

Silence Therapeutics losses deepen as lead drugs near trials

(Sharecast News) - Biotechnology firm Silence Therapeutics shares fell on Tuesday after reporting a first half loss after tax of Ā£8.7m, up 57%, due to costs associated with bringing its two lead programmes towards the clinic.

Read more
11 Sep 2018 11:16

Silence Therapeutics Interim Loss Widens As Research Costs Surge

LONDON (Alliance News) - Silence Therapeutics PLC said Tuesday that its loss for the first half of the financial year widened as research & development costs jumped.Shares in the were a

Read more
4 Sep 2018 15:54

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 5 SeptemberĀ Barratt DevelopmentsFull Year ResultsBreedon GroupHalf Year Year 6

Read more
20 Aug 2018 10:44

Silence Therapeutics Executive Chair Jenkins Steps Down

LONDON (Alliance News) - Silence Therapeutics PLC said Monday that Executive Chair Annalisa Jenkins will be leaving her role with immediate effect after 11 months into the role.The company

Read more
21 Jun 2018 11:07

Silence Therapeutics Appoints Dave Lemus As Non-Executive Director

LONDON (Alliance News) - Silence Therapeutics PLC said Thursday it appointed Dave Lemus to the board as non-executive director effective immediately.The company focused on the discovery and

Read more
15 Jun 2018 11:28

Silence Therapeutics Gets Promising Data From Iron Disorder Treatment

LONDON (Alliance News) - Silence Therapeutics PLC said Friday its compound for the treatment of iron overload disorders may "provide a safe, effective and patient-friendly therapeutic Project

Read more
4 Jun 2018 11:15

Silence Therapeutics Boss Ali Mortazavi Leaves After Six Years

LONDON (Alliance News) - Silence Therapeutics PLC on Monday announced the departure of Chief Executive Ali Mortazavi with immediate effect after six years in the job.He will be replaced as

Read more
3 Apr 2018 13:49

Silence Therapeutics Files Patent Violation Claim Against Alnylam

LONDON (Alliance News) - Silence Therapeutics PLC said Tuesday it has begun patent infringement proceedings in Portugal against Alnylam Pharmaceutical a a

Read more
6 Mar 2018 12:50

Silence Therapeutics Loss Narrows On Asset Sale As Ponders US Listing (ALLIPO)

LONDON (Alliance News) - Silence Therapeutics PLC said Tuesday its full year loss narrowed after profitable share sales of its NASDAQ-listed peer Arrowhead Pharmaceutical Inc

Read more
13 Jan 2017 14:19

Silence confirms minority stake in Arrowhead Pharmaceuticals

(ShareCast News) - Discoverer, deliverer and developer of novel RNA therapeutics for the treatment of serious diseases, Silence Therapeutics updated the market on its announcement on 9 January regarding the acquisition of a minority stake in Arrowhead Pharmaceuticals. The AIM-traded company said it

Read more
9 Jan 2017 08:18

Silence Therapeutics buys stake in US-based Arrowhead Parma

(ShareCast News) - Silence Therapeutics, a developer of ribonucleic acid (RNA) treatments, has bought an 8.4% stake in Nasdaq-listed Arrowowhead Pharmaceuticals for $7.8m ($9.6m). The AIM-listed company bought the minority stake, which represents about 6m shares in the US pharmaceutical's share c

Read more
20 Dec 2016 12:13

Silence Therapeutics, Quark Pharmaceuticals reach settlement

(ShareCast News) - Silence Therapeutics said it has reached a settlement in the arbitration process with Quark Pharmaceuticals, with the former to receive a $1m cash payment. Under the terms of the agreement, AIM-listed Silence was also eligible to receive either about 2% royalties from Quark plus m

Read more
20 Dec 2016 08:27

Silence Therapeutics Reaches Settlement With Quark Pharmaceuticals

Read more
15 Nov 2016 10:43

Silence Therapeutics To Present Gene Editing Data At Berlin Conference

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.